Literature DB >> 3276626

Affinity-purified antibodies to ring-infected erythrocyte surface antigen do not correlate with merozoite invasion inhibition in Plasmodium falciparum.

J P Coleman1, J B Jensen.   

Abstract

We affinity purified, from malaria-immune serum, antibody to the ring-infected erythrocyte surface antigen (RESA), using petri dishes containing a monolayer of Plasmodium falciparum ring-infected erythrocytes. Except for one out of eight samples, the purified antibody positive by RESA-immunofluorescent assay was not inhibitory to the in vitro invasion of merozoites into erythrocytes in three geographically distinct strains of P. falciparum. However, the initial high level of merozoite-inhibiting antibodies of the intact serum samples remained in the immunoglobulin G fraction from which the RESA antibodies had been removed by affinity chromatography. These results suggest that, although in some cases RESA-immunofluorescent assay-positive antibodies may be inhibitory to merozoite invasion, there are more important antibodies capable of merozoite invasion inhibition.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3276626      PMCID: PMC259304          DOI: 10.1128/iai.56.2.457-461.1988

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  20 in total

1.  Concentration from continuous culture of erythrocytes infected with trophozoites and schizonts of Plasmodium falciparum.

Authors:  J B Jensen
Journal:  Am J Trop Med Hyg       Date:  1978-11       Impact factor: 2.345

2.  Plasmodium falciparum: rapid assay for in vitro inhibition due to human serum from residents of malarious areas.

Authors:  J B Jensen; M T Boland; M Hayes; M A Akood
Journal:  Exp Parasitol       Date:  1982-12       Impact factor: 2.011

3.  Serum inhibition of merozoite dispersal from Plasmodium falciparum schizonts: indicator of immune status.

Authors:  T J Green; M Morhardt; R G Brackett; R L Jacobs
Journal:  Infect Immun       Date:  1981-03       Impact factor: 3.441

4.  Inhibitory effects of immune monkey serum on synchronized Plasmodium falciparum cultures.

Authors:  J D Chulay; M Aikawa; C Diggs; J D Haynes
Journal:  Am J Trop Med Hyg       Date:  1981-01       Impact factor: 2.345

5.  Malaria (Plasmodium knowlesi) merozoites: immunity and the surface coat.

Authors:  L H Miller; M Aikawa; J A Dvorak
Journal:  J Immunol       Date:  1975-04       Impact factor: 5.422

6.  Longitudinal study on the in vitro immune response to Plasmodium falciparum in Sudan.

Authors:  J A Vande Waa; J B Jensen; M A Akood; R Bayoumi
Journal:  Infect Immun       Date:  1984-08       Impact factor: 3.441

Review 7.  Invasion of erythrocytes by malaria parasites: a cellular and molecular overview.

Authors:  T J Hadley
Journal:  Annu Rev Microbiol       Date:  1986       Impact factor: 15.500

8.  Synchronization of Plasmodium falciparum erythrocytic stages in culture.

Authors:  C Lambros; J P Vanderberg
Journal:  J Parasitol       Date:  1979-06       Impact factor: 1.276

9.  Cultured Plasmodium falciparum used as antigen in a malaria indirect fluorescent antibody test.

Authors:  C L Hall; J D Haynes; J D Chulay; C L Diggs
Journal:  Am J Trop Med Hyg       Date:  1978-09       Impact factor: 2.345

10.  Antibodies in malarial sera to parasite antigens in the membrane of erythrocytes infected with early asexual stages of Plasmodium falciparum.

Authors:  H Perlmann; K Berzins; M Wahlgren; J Carlsson; A Björkman; M E Patarroyo; P Perlmann
Journal:  J Exp Med       Date:  1984-06-01       Impact factor: 14.307

View more
  2 in total

1.  Opsonization and phagocytosis of Plasmodium falciparum merozoites measured by flow cytometry.

Authors:  L M Kumaratilake; A Ferrante
Journal:  Clin Diagn Lab Immunol       Date:  2000-01

2.  Babesia divergens and Plasmodium falciparum use common receptors, glycophorins A and B, to invade the human red blood cell.

Authors:  Cheryl-Ann Lobo
Journal:  Infect Immun       Date:  2005-01       Impact factor: 3.441

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.